HelioLiver LDT now available to order through Quest Diagnostics
Modern corporate skyline
Helio Genomics · Newsroom

Investor Relations

Recent press coverage and publications have highlighted Helio Genomics' market momentum in early cancer detection and diagnostics innovation.

Featured Coverage

Business Insider67.7M Monthly Visitors

Helio Genomics Announces New HelioLiver Access Through Quest

Business Insider covers the expanded provider access for HelioLiver beginning April 2026, detailing how healthcare providers with existing Quest accounts can order the blood-based liver cancer test through Quest's infrastructure of approximately 7,700 patient service centers and EHR integration.

Read the Coverage

In the Press

Helio Genomics' science, commercial milestones, and the Quest Diagnostics partnership have been covered across leading financial, industry, and clinical media.

Life Science Daily: How Blood-Based Testing Could Close the Cancer Detection GapMedia
Jul 24, 2026

Life Science Daily: How Blood-Based Testing Could Close the Detection Gap

Read on
citybiz: Helio Appoints Healthcare AI Executive Parminder Bhatia to BoardMedia
Jul 16, 2026

citybiz: Helio Appoints Healthcare AI Executive Parminder Bhatia to Board

Read on
360Dx: Parminder Bhatia Appointed to Helio Genomics’ BoardMedia
Jul 16, 2026

360Dx: Parminder Bhatia Appointed to Helio Genomics’ Board

Read on
Third News: Parminder Bhatia Joins Helio’s Board to Advance AI DiagnosticsMedia
Jul 16, 2026

Third News: Parminder Bhatia Joins Helio’s Board to Advance AI Diagnostics

Read on
Healthcare AI Leader Parminder Bhatia Joins Helio BoardMedia
Jul 16, 2026

PR Newswire: Healthcare AI Leader Parminder Bhatia Joins Helio Board

Read on
Why AI Multiomics Will Replace Ultrasound in Liver Cancer ScreeningMedia
Jun 30, 2026

Apple Podcasts: Why AI + Multiomics Will Replace Liver Cancer Ultrasound

Read on
Can GLP-1s Treat Cancer? Ozempic and Cancer Risk ExplainedMedia
Jun 30, 2026

U.S. News: Can GLP-1s Like Ozempic Affect Liver Cancer Risk?

Read on
DeciBio: Helio Genomics in May 2026 Liquid Biopsy Round-UpMedia
Jun 16, 2026

DeciBio: Helio Genomics in May 2026 Liquid Biopsy Round-Up

Read on
Helio Genomics Named in Global IVD Market Forecast to 2036Media
Jun 12, 2026

OpenPR: Helio Genomics Named in Global IVD Market Forecast to 2036

Read on
TechBullion: Rural Healthcare Drives New Models for Earlier DetectionMedia
May 20, 2026

TechBullion: Rural Healthcare Drives New Models for Earlier Detection

Read on
360Dx: Helio and Syneos Health Broaden Liver Cancer CommercializationMedia
May 19, 2026

360Dx: Helio and Syneos Health Broaden Liver Cancer Commercialization

Read on
PR Newswire: Helio & Syneos Health Partner to Scale HelioLiver NationwideMedia
May 19, 2026

PR Newswire: Helio & Syneos Health Partner to Scale HelioLiver Nationwide

Read on
Investing: HelioLiver Expands Access Through Quest DiagnosticsMedia
May 12, 2026

Investing: HelioLiver Expands Access Through Quest Diagnostics

Read on
RHT Collaborative on LinkedIn: Helio Joins Microsoft Rural HealthMedia
May 8, 2026

RHT Collaborative on LinkedIn: Helio Joins Microsoft Rural Health

Read on
MedPage Today: Helio Featured in Liver Cancer Blood Test RoundupMedia
May 7, 2026

MedPage Today: Helio Featured in Liver Cancer Blood Test Roundup

Read on
OncoDaily: Achyut Saroj on Seeing the Invisible Liver Cancer Blind SpotMedia
May 6, 2026

OncoDaily: Achyut Saroj on Seeing the Invisible Liver Cancer Blind Spot

Read on
Third News: HelioLiver Outperforms Ultrasound in HCC DetectionMedia
May 6, 2026

Third News: HelioLiver Outperforms Ultrasound in HCC Detection

Read on
Journal of Hepatology Publishes Landmark HelioLiver CLiMB StudyMedia
May 6, 2026

Journal of Hepatology Publishes Landmark HelioLiver CLiMB Study

Read on
OncoDaily: Bharat Tewarie on a Real Fighting Chance Against Liver CancerMedia
May 6, 2026

OncoDaily: Bharat Tewarie on a Real Fighting Chance Against Liver Cancer

Read on
Noah News: Helio and Syneos Health Partner to Speed Liver Cancer DetectionMedia
May 6, 2026

Noah News: Helio and Syneos Health Partner to Speed Liver Cancer Detection

Read on
NGSX Substack: Helio Genomics & Syneos Health Announce PartnershipMedia
Apr 21, 2026

NGSX Substack: Helio Genomics & Syneos Health Announce Partnership

Read on
Third News: Helio & Syneos Health Enhance AI Liver Cancer DiagnosticsMedia
Apr 21, 2026

Third News: Helio & Syneos Health Enhance AI Liver Cancer Diagnostics

Read on
OncData: Expanding Early HCC Detection with HelioLiverMedia
Apr 15, 2026

OncData: Expanding Early HCC Detection with HelioLiver

Read on
Orange County Business Journal coverageMedia
Apr 13, 2026

Orange County Business Journal: Helio Enters Full Launch with Quest

Read on
FinanceWire coverageMedia
Mar 30, 2026

FinanceWire: Helio Genomics Announces New HelioLiver Access Through Quest

Read on
Dealroom.co coverageMedia
Mar 28, 2026

Dealroom: Quest to Offer Helio’s AI-Powered Liver Cancer Blood Test

Read on
Yahoo! News coverageMedia
Mar 25, 2026

Yahoo News: Improving Early Detection and Treatment of Liver Cancer

Read on
GlobalData coverageMedia
Mar 25, 2026

GlobalData: Improving Early Detection and Treatment of Liver Cancer

Read on
SAHM Capital coverageMedia
Mar 25, 2026

Sahm Capital: Quest’s Cancer Screening Push & the Investor View

Read on
Simply Wall St. News coverageMedia
Mar 22, 2026

Simply Wall St: What Quest’s Cancer Screening Push Means for Investors

Read on
Scope Forward (Becker's GI & Endoscopy) coverageMedia
Mar 20, 2026

Scope Forward: Quest Diagnostics to Offer Liver Cancer Blood Test

Read on
LiverRight coverageMedia
Mar 20, 2026

LiverRight: Helio Genomics and Quest Diagnostics

Read on
Becker's ASC Review coverageMedia
Mar 19, 2026

Becker’s ASC Review: Quest Diagnostics to Offer Liver Cancer Blood Test

Read on
NewsBreak coverageMedia
Mar 19, 2026

NewsBreak: Quest Diagnostics to Offer Liver Cancer Blood Test

Read on
Brief Glance coverageMedia
Mar 18, 2026

Brief Glance: AI Blood Test for Liver Cancer Gains Reach via Quest Deal

Read on
Business Wire: HelioLiver Now Available to Quest Diagnostics’ ProvidersMedia
Mar 16, 2026

Business Wire: HelioLiver Now Available to Quest Diagnostics’ Providers

Read on
PR Newswire: Helio Genomics Announces LiverRight Strategic PartnershipMedia
Dec 15, 2025

PR Newswire: Helio Genomics Announces LiverRight Strategic Partnership

Read on
American Liver Foundation & Helio Launch LiverTrace PartnershipMedia
Dec 8, 2025

American Liver Foundation & Helio Launch LiverTrace Partnership

Read on
PR Newswire: Helio Genomics Presents Three Abstracts at DDW 2025Media
May 6, 2025

PR Newswire: Helio Genomics Presents Three Abstracts at DDW 2025

Read on
GlobeNewswire: Helio Presents CLiMB Data at AASLD & KOL Event 2024Media
Nov 26, 2024

GlobeNewswire: Helio Presents CLiMB Data at AASLD & KOL Event 2024

Read on
GlobeNewswire: Dr. Van Etten to Present Helio CLiMB Data at AASLD 2024Media
Nov 12, 2024

GlobeNewswire: Dr. Van Etten to Present Helio CLiMB Data at AASLD 2024

Read on
BioSpace: Helio Methylation Score Named Top Abstract, San Antonio 2024Media
Oct 15, 2024

BioSpace: Helio Methylation Score Named Top Abstract, San Antonio 2024

Read on
PR Newswire: Helio CEO Justin Chen Li Joins Terasaki Leadership BoardMedia
Sep 24, 2024

PR Newswire: Helio CEO Justin Chen Li Joins Terasaki Leadership Board

Read on
GlobeNewswire: Helio Appoints Eric Ariazi as Chief Development OfficerMedia
Aug 5, 2024

GlobeNewswire: Helio Appoints Eric Ariazi as Chief Development Officer

Read on
GlobeNewswire: Helio Separates from Laboratory for Advanced MedicineMedia
Jul 2, 2024

GlobeNewswire: Helio Separates from Laboratory for Advanced Medicine

Read on
LabMedica: Blood-Based Test Outperforms Ultrasound in Early Liver CancerMedia
Jun 14, 2024

LabMedica: Blood-Based Test Outperforms Ultrasound in Early Liver Cancer

Read on
BioSpace: HelioLiver Dx Meets CLiMB Trial Endpoints at EASL 2024Media
Jun 10, 2024

BioSpace: HelioLiver Dx Meets CLiMB Trial Endpoints at EASL 2024

Read on
BioSpace: Helio to Showcase CLiMB Pivotal Trial Data at EASL 2024Media
May 6, 2024

BioSpace: Helio to Showcase CLiMB Pivotal Trial Data at EASL 2024

Read on
Precision Medicine Online coverageMedia
Mar 22, 2024

Precision Medicine Online: Helio Mulls New AI-Driven Dx Opportunities

Read on
PR Newswire: Helio Genomics Appoints Gary Frazier as Chief Growth OfficerMedia
Feb 6, 2024

PR Newswire: Helio Genomics Appoints Gary Frazier as Chief Growth Officer

Read on
Genome Medicine Publishes Helio-UC Irvine Colorectal Cancer StudyMedia
Jan 16, 2024

Genome Medicine Publishes Helio-UC Irvine Colorectal Cancer Study

Read on
PM360: HelioLiver Featured in 11th Annual Innovations IssueMedia
Dec 15, 2022

PM360: HelioLiver Featured in 11th Annual Innovations Issue

Read on
DOTmed News: October Is Liver Cancer Awareness MonthMedia
Oct 25, 2022

DOTmed News: October Is Liver Cancer Awareness Month

Read on
PR Newswire: Helio Genomics Named Frost & Sullivan Company of the YearMedia
Oct 12, 2022

PR Newswire: Helio Genomics Named Frost & Sullivan Company of the Year

Read on
IMPACT 22: Helio Genomics Recognized as Healthcare Technology of the YearMedia
Oct 8, 2022

IMPACT 22: Helio Genomics Recognized as Healthcare Technology of the Year

Read on
IMPACT 22: Joyce Cheung Receives Women in Leadership AwardMedia
Oct 8, 2022

IMPACT 22: Joyce Cheung Receives Women in Leadership Award

Read on
OCBJ: 5 Innovators Honored at the OC Business Journal AwardsMedia
Sep 12, 2022

OCBJ: 5 Innovators Honored at the OC Business Journal Awards

Read on
PRweb: Dhruv Roy Joins Onco’Zine Editorial Advisory BoardMedia
Aug 19, 2022

PRweb: Dhruv Roy Joins Onco’Zine Editorial Advisory Board

Read on
PR Newswire: AMA Approves Category I CPT Code for HelioLiver TestMedia
Jul 5, 2022

PR Newswire: AMA Approves Category I CPT Code for HelioLiver Test

Read on
Nature: Advancing Earlier Liver Cancer Detection with Blood TestingMedia
Jul 5, 2022

Nature: Advancing Earlier Liver Cancer Detection with Blood Testing

Read on
PR Newswire: Helio Health Wins 2nd Consecutive MedTech Breakthrough AwardMedia
May 5, 2022

PR Newswire: Helio Health Wins 2nd Consecutive MedTech Breakthrough Award

Read on
Business Wire: HelioLiver Liquid Biopsy Test Now Commercially AvailableMedia
Dec 6, 2021

Business Wire: HelioLiver Liquid Biopsy Test Now Commercially Available

Read on
PR Newswire: Helio & Fulgent Report Positive HelioLiver Trial DataMedia
Nov 8, 2021

PR Newswire: Helio & Fulgent Report Positive HelioLiver Trial Data

Read on
PR Newswire: Helio & Fulgent to Present HelioLiver Data at Liver MeetingMedia
Nov 1, 2021

PR Newswire: Helio & Fulgent to Present HelioLiver Data at Liver Meeting

Read on
Fulgent Genetics: Strategic Partnership with Helio for Early DetectionMedia
Aug 9, 2021

Fulgent Genetics: Strategic Partnership with Helio for Early Detection

Read on
PR Newswire: FUJIFILM & Helio Collaborate on Blood-Based Liver ScreeningMedia
May 12, 2021

PR Newswire: FUJIFILM & Helio Collaborate on Blood-Based Liver Screening

Read on
PR Web: MedTech Breakthrough Helio Health Honored in 2021 Awards ProgramMedia
May 6, 2021

PR Web: MedTech Breakthrough Helio Health Honored in 2021 Awards Program

Read on
PR Newswire: Helio & NCC China Win Ministry of Science & Tech GrantMedia
Apr 28, 2021

PR Newswire: Helio & NCC China Win Ministry of Science & Tech Grant

Read on
Onco’Zine: Dhruv Roy on ctDNA Methylation as a Diagnostic ApproachMedia
Mar 20, 2020

Onco’Zine: Dhruv Roy on ctDNA Methylation as a Diagnostic Approach

Read on
GEN: LAM’s New CEO Sharpens Commercial FocusMedia
Feb 21, 2020

GEN: LAM’s New CEO Sharpens Commercial Focus

Read on
Machine Learning with Cancer Methylation Signatures to Diagnose Colorectal CancerMedia
Jan 3, 2020

Medical Xpress: Machine Learning Detects CRC via Methylation

Read on
Clinical OMICs: ctDNA Methylation for Colorectal CancerMedia
Jan 3, 2020

Clinical OMICs: ctDNA Methylation for Colorectal Cancer

Read on
Circulating Tumor DNA Methylation Profiles May Aid in Colorectal Cancer Early DiagnosisMedia
Jan 2, 2020

Precision Oncology News: ctDNA Methylation in Colorectal Cancer

Read on
Cheddar: LAM Raises $86M for Breakthrough Liver Cancer TestMedia
Nov 15, 2019

Cheddar: LAM Raises $86M for Breakthrough Liver Cancer Test

Read on
OCBJ: Cancer Diagnostic Firm LAM on Growth PathMedia
Nov 13, 2019

OCBJ: Cancer Diagnostic Firm LAM on Growth Path

Read on
AncestryDNA chief takes on liquid biopsy challenge; Thomas Lynch chairs former colleague’s cancer startupMedia
Nov 8, 2019

Endpoints News: Chahine on the Liquid Biopsy Challenge

Read on
Technology Networks: DNA Methylation for Early Cancer Detection Q&AMedia
Jun 11, 2019

Technology Networks: DNA Methylation for Early Cancer Detection Q&A

Read on
FiOS1 News: Blood Test Aids Early Cancer DetectionMedia
Oct 28, 2018

FiOS1 News: Blood Test Aids Early Cancer Detection

Read on
City of Mission, TX: Cancer Screenings for Firefighters via IvyGeneMedia
Apr 13, 2018

City of Mission, TX: Cancer Screenings for Firefighters via IvyGene

Read on
LAM’s research collaborators at UCSD prove that non-invasive blood testing may find liver cancer earlier and improve survival – San Diego Union TribuneMedia
Oct 9, 2017

San Diego Union-Tribune: Blood Test Finds Liver Cancer Earlier

Read on
Nature Materials: Liquid Biopsy Detects Liver Cancer EarlierMedia
Oct 9, 2017

Nature Materials: Liquid Biopsy Detects Liver Cancer Earlier

Read on
Peer-Reviewed Science

Our Publications

For over a decade, Helio Genomics’ science has been published in the world’s most respected peer-reviewed journals — the research behind HelioLiver and the platform that powers it.

13+Years of published
science
9Peer-reviewed
publications
2Cancer indications
(HCC & CRC)
Molecular Cell2013

Genome-Wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates

A large-scale clinical study on cfDNA methylation in relation to aging and age-related diseases, where Helio’s science began.

Open Publication pubmed.ncbi.nlm.nih.gov
Proceedings of the National Academy of Sciences (PNAS)2017

DNA Methylation Markers for Diagnosis and Prognosis of Common Cancers

A large-scale clinical study across liver, colon, lung, and breast cancers, validating new DNA methylation markers.

Open Publication pnas.org
Nature Materials2017

Circulating Tumor DNA Methylation Markers for Diagnosis and Prognosis of Hepatocellular Carcinoma

A large-scale clinical study of cfDNA methylation markers in the detection of HCC.

Open Publication nature.com
Science Translational Medicine2020

Circulating Tumor DNA Methylation Profiles Enable Early Diagnosis, Prognosis Prediction, and Screening for Colorectal Cancer

A large-scale clinical study of cfDNA methylation markers in the detection of colorectal cancer (CRC).

Open Publication science.org
Nature Communications2021

Cellular Heterogeneity–Adjusted cLonal Methylation (CHALM) Improves Prediction of Gene Expression

An advanced bioinformatics algorithm that strengthens how methylation data predicts gene expression, part of the science behind Helio’s platform.

Open Publication nature.com
Hepatology Communications2022

A Multi-Analyte Cell-Free DNA–Based Blood Test for Early Detection of Hepatocellular Carcinoma

The ENCORE study. Clinical validation of the HelioLiver product for early HCC detection.

Open Publication pubmed.ncbi.nlm.nih.gov
Journal of HepatologyLatest · 2026

A Multi-Analyte cfDNA-Based Blood Test for Early Detection of Hepatocellular Carcinoma

The pivotal CLiMB trial. HelioLiver detected liver cancer earlier than ultrasound in a large, prospective US study of high-risk patients.

Open Publication journal-of-hepatology.eu
Molecular Cancer2023

Efficacy of a Cell-Free DNA Methylation-Based Blood Test for Colorectal Cancer Screening in a High-Risk Population: A Prospective Cohort Study

Clinical validation of the colorectal cancer screening test in a high-risk population.

Open Publication molecular-cancer.biomedcentral.com
Genome Medicine2024

Multimodal Epigenetic Sequencing Analysis (MESA) of Cell-Free DNA for Non-Invasive Colorectal Cancer Detection

A multimodal sequencing approach for non-invasive colorectal cancer detection.

Open Publication genomemedicine.biomedcentral.com
View All Publications